Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 15,000 shares at $8.73 on Sept. 26, 2013. Following this transaction, the CEO & Chairman owned 136.8 million shares meaning that the stake was reduced by 0.01% with the 15,000 share transaction.

The shares most recently traded at $8.64, down $0.09, or 1.09% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 24-Week # shares bought: 4,300

The average volume for Opko Health has been 2.7 million shares per day over the past 30 days. Opko Health has a market cap of $3.5 billion and is part of the health care sector and health services industry. Shares are up 81.5% year to date as of the close of trading on Thursday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Sapient (SAPE) Showing Signs Of Being Strong And Under The Radar

Don't Miss Today's Strong And Under The Radar Stock: Sapient (SAPE)

Watch Out: Barbarians At The Gate For Sapient (SAPE)

Sapient (SAPE) Stock Closed Lower Today After Fiduciary Duty Investigation Launched

Today's Unusual Social Activity Stock: Sapient (SAPE)